- Home
- CLLS vs IIIV Comparison
CLLS vs IIIV Comparison
Compare CLLS & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLLS | IIIV |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.5M | 565.5M |
| IPO Year | 2007 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CLLS | IIIV |
|---|---|---|
| Price | $4.23 | $26.70 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $8.50 | ★ $33.33 |
| AVG Volume (30 Days) | 102.1K | ★ 275.5K |
| Earning Date | 11-07-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.56 |
| Revenue | $82,551,000.00 | ★ $213,158,000.00 |
| Revenue This Year | $32.58 | $8.32 |
| Revenue Next Year | $20.68 | $7.26 |
| P/E Ratio | ★ N/A | $196.00 |
| Revenue Growth | ★ 129.04 | 11.47 |
| 52 Week Low | $1.10 | $22.00 |
| 52 Week High | $5.48 | $33.97 |
Technical Indicators
Market Signals| Indicator | CLLS | IIIV |
|---|---|---|
| Relative Strength Index (RSI) | 42.69 | 56.28 |
| Support Level | $4.37 | $24.85 |
| Resistance Level | $4.68 | $27.86 |
| Average True Range (ATR) | 0.24 | 0.91 |
| MACD | -0.07 | 0.22 |
| Stochastic Oscillator | 6.97 | 73.85 |
Price Performance
Historical ComparisonAbout CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About IIIV i3 Verticals Inc.
i3 Verticals Inc provides mission-critical enterprise software solutions to public sector entities. These comprehensive cloud-native solutions address a broad range of government functions, including courts and public safety, public administration, utilities, transportation and schools. The company generates the majority of revenue from software and related services, including the sale of subscriptions, recurring services, ongoing support, licenses, and installation and implementation services specific to software.